381 related articles for article (PubMed ID: 26130743)
1. From the clinician's point of view - What is the status quo of positron emission tomography in patients with brain tumors?
Galldiks N; Langen KJ; Pope WB
Neuro Oncol; 2015 Nov; 17(11):1434-44. PubMed ID: 26130743
[TBL] [Abstract][Full Text] [Related]
2. An interindividual comparison of O-(2-[18F]fluoroethyl)-L-tyrosine (FET)- and L-[methyl-11C]methionine (MET)-PET in patients with brain gliomas and metastases.
Grosu AL; Astner ST; Riedel E; Nieder C; Wiedenmann N; Heinemann F; Schwaiger M; Molls M; Wester HJ; Weber WA
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):1049-58. PubMed ID: 21570201
[TBL] [Abstract][Full Text] [Related]
3. Imaging of amino acid transport in brain tumours: Positron emission tomography with O-(2-[
Langen KJ; Stoffels G; Filss C; Heinzel A; Stegmayr C; Lohmann P; Willuweit A; Neumaier B; Mottaghy FM; Galldiks N
Methods; 2017 Nov; 130():124-134. PubMed ID: 28552264
[TBL] [Abstract][Full Text] [Related]
4. The use of amino acid PET and conventional MRI for monitoring of brain tumor therapy.
Galldiks N; Law I; Pope WB; Arbizu J; Langen KJ
Neuroimage Clin; 2017; 13():386-394. PubMed ID: 28116231
[TBL] [Abstract][Full Text] [Related]
5. Usefulness of positron emission tomographic studies for gliomas.
Miyake K; Ogawa D; Okada M; Hatakeyama T; Tamiya T
Neurol Med Chir (Tokyo); 2016 Jul; 56(7):396-408. PubMed ID: 27250577
[TBL] [Abstract][Full Text] [Related]
6. Accuracy of
Yu J; Zheng J; Xu W; Weng J; Gao L; Tao L; Liang F; Zhang J
World Neurosurg; 2018 Jun; 114():e1211-e1224. PubMed ID: 29625311
[TBL] [Abstract][Full Text] [Related]
7. Clinical value of O-(2-[(18)F]-fluoroethyl)-L-tyrosine positron emission tomography in patients with low-grade glioma.
Rapp M; Floeth FW; Felsberg J; Steiger HJ; Sabel M; Langen KJ; Galldiks N
Neurosurg Focus; 2013 Feb; 34(2):E3. PubMed ID: 23373448
[TBL] [Abstract][Full Text] [Related]
8. Application of Artificial Intelligence in Oncologic Molecular PET-Imaging: A Narrative Review on Beyond [
Eisazadeh R; Shahbazi-Akbari M; Mirshahvalad SA; Pirich C; Beheshti M
Semin Nucl Med; 2024 Mar; 54(2):293-301. PubMed ID: 38331629
[TBL] [Abstract][Full Text] [Related]
9. Comparison of (18)F-FET and (18)F-FDG PET in brain tumors.
Pauleit D; Stoffels G; Bachofner A; Floeth FW; Sabel M; Herzog H; Tellmann L; Jansen P; Reifenberger G; Hamacher K; Coenen HH; Langen KJ
Nucl Med Biol; 2009 Oct; 36(7):779-87. PubMed ID: 19720290
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic Accuracy of PET Tracers for the Differentiation of Tumor Progression from Treatment-Related Changes in High-Grade Glioma: A Systematic Review and Metaanalysis.
de Zwart PL; van Dijken BRJ; Holtman GA; Stormezand GN; Dierckx RAJO; Jan van Laar P; van der Hoorn A
J Nucl Med; 2020 Apr; 61(4):498-504. PubMed ID: 31541032
[TBL] [Abstract][Full Text] [Related]
11. Comparison of 18F-FET PET and perfusion-weighted MR imaging: a PET/MR imaging hybrid study in patients with brain tumors.
Filss CP; Galldiks N; Stoffels G; Sabel M; Wittsack HJ; Turowski B; Antoch G; Zhang K; Fink GR; Coenen HH; Shah NJ; Herzog H; Langen KJ
J Nucl Med; 2014 Apr; 55(4):540-5. PubMed ID: 24578243
[TBL] [Abstract][Full Text] [Related]
12. Glioma Recurrence Versus Radiation Necrosis: Single-Session Multiparametric Approach Using Simultaneous O-(2-18F-Fluoroethyl)-L-Tyrosine PET/MRI.
Jena A; Taneja S; Gambhir A; Mishra AK; Dʼsouza MM; Verma SM; Hazari PP; Negi P; Jhadav GK; Sogani SK
Clin Nucl Med; 2016 May; 41(5):e228-36. PubMed ID: 26859208
[TBL] [Abstract][Full Text] [Related]
13. Current Landscape and Emerging Fields of PET Imaging in Patients with Brain Tumors.
Werner JM; Lohmann P; Fink GR; Langen KJ; Galldiks N
Molecules; 2020 Mar; 25(6):. PubMed ID: 32213992
[TBL] [Abstract][Full Text] [Related]
14. High-grade glioma radiation therapy target volumes and patterns of failure obtained from magnetic resonance imaging and 18F-FDOPA positron emission tomography delineations from multiple observers.
Kosztyla R; Chan EK; Hsu F; Wilson D; Ma R; Cheung A; Zhang S; Moiseenko V; Benard F; Nichol A
Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):1100-6. PubMed ID: 24161427
[TBL] [Abstract][Full Text] [Related]
15. Recent Developments of 18F-FET PET in Neuro-oncology.
Muoio B; Giovanella L; Treglia G
Curr Med Chem; 2018; 25(26):3061-3073. PubMed ID: 29173147
[TBL] [Abstract][Full Text] [Related]
16. Current trends in the use of O-(2-[
Stegmayr C; Stoffels G; Filß C; Heinzel A; Lohmann P; Willuweit A; Ermert J; Coenen HH; Mottaghy FM; Galldiks N; Langen KJ
Nucl Med Biol; 2021 Jan; 92():78-84. PubMed ID: 32113820
[TBL] [Abstract][Full Text] [Related]
17. Imaging gliomas with positron emission tomography and single-photon emission computed tomography.
Bénard F; Romsa J; Hustinx R
Semin Nucl Med; 2003 Apr; 33(2):148-62. PubMed ID: 12756647
[TBL] [Abstract][Full Text] [Related]
18. [Improved diagnostics of cerebral gliomas using FET PET].
Langen KJ; Floeth FW; Stoffels G; Hamacher K; Coenen HH; Pauleit D
Z Med Phys; 2007; 17(4):237-41. PubMed ID: 18254545
[TBL] [Abstract][Full Text] [Related]
19. The Utility of Conventional Amino Acid PET Radiotracers in the Evaluation of Glioma Recurrence also in Comparison with MRI.
Santo G; Laudicella R; Linguanti F; Nappi AG; Abenavoli E; Vergura V; Rubini G; Sciagrà R; Arnone G; Schillaci O; Minutoli F; Baldari S; Quartuccio N; Bisdas S
Diagnostics (Basel); 2022 Mar; 12(4):. PubMed ID: 35453892
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of F-18-labeled amino acid derivatives and [18F]FDG as PET probes in a brain tumor-bearing animal model.
Wang HE; Wu SY; Chang CW; Liu RS; Hwang LC; Lee TW; Chen JC; Hwang JJ
Nucl Med Biol; 2005 May; 32(4):367-75. PubMed ID: 15878506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
